Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer

This phase II study was conducted to determine the efficacy and toxicity of a gemcitabine (GEM) and oxaliplatin (OX) chemotherapy protocol in patients with unresectable biliary tract cancer (BTC). Patients were treated with GEM 1000 mg m(−2) (30 min infusion) on days 1, 8, 15, and OX 100 mg m(−2) (2...

Descripción completa

Detalles Bibliográficos
Autores principales: Harder, J, Riecken, B, Kummer, O, Lohrmann, C, Otto, F, Usadel, H, Geissler, M, Opitz, O, Henß, H
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2006
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360533/
https://www.ncbi.nlm.nih.gov/pubmed/16969352
http://dx.doi.org/10.1038/sj.bjc.6603334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360533/
https://www.ncbi.nlm.nih.gov/pubmed/16969352
http://dx.doi.org/10.1038/sj.bjc.6603334

Ejemplares similares